Ocugen (OCGN) Retained Earnings (2014 - 2026)
Ocugen (OCGN) reported Retained Earnings of -$427.2 million for Q1 2026, down 20.16% on a YoY basis from -$535.1 million in Q1 2025, and down 700500.0% quarter-over-quarter from $61000.0 in Q4 2025.
Ocugen (OCGN) Retained Earnings (2014 - 2026) Analysis & Trends
Ocugen has reported Retained Earnings for 13 years, with the latest figure at -$427.2 million in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings fell 20.16% year-over-year to -$427.2 million; the trailing twelve-month figure through Mar 2026 stood at -$427.2 million (down 20.16% YoY), and the FY2025 full-year result was $61000.0, up 27.08% from the prior year.
- Retained Earnings for Q1 2026 stood at -$427.2 million, down from $61000.0 in the prior quarter.
- The five-year high for Retained Earnings was $61000.0 in Q4 2025, with the low at -$427.2 million in Q1 2026.
- Historically, Retained Earnings has averaged -$190.4 million across 5 years, with a median of -$223.1 million in 2022.
- Annual changes were most pronounced in 2022 — Retained Earnings jumped 100.03% — and 2025, when it tumbled 1697321.74%.
- Ocugen's Retained Earnings stood at -$223.1 million in 2022, then declined by 28.27% to -$286.2 million in 2023, then surged by 100.02% to $48000.0 in 2024, then gained by 27.08% to $61000.0 in 2025, then plunged by 700500.0% to -$427.2 million in 2026.
- The last three Retained Earnings figures came in at -$427.2 million (Q1 2026), $61000.0 (Q4 2025), and -$390.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Ocugen | 411.07 Mn | 411.07 Mn | - | -427.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -427.24 Mn |
| Dec 31, 2025 | 61,000.00 |
| Sep 30, 2025 | -390.36 Mn |
| Jun 30, 2025 | -370.31 Mn |
| Mar 31, 2025 | -355.57 Mn |
| Dec 31, 2024 | 48,000.00 |
| Sep 30, 2024 | 23,000.00 |
| Jun 30, 2024 | -313.37 Mn |
| Mar 31, 2024 | 25,000.00 |
| Dec 31, 2023 | -286.17 Mn |
| Sep 30, 2023 | -275.20 Mn |
| Jun 30, 2023 | -263.48 Mn |
| Mar 31, 2023 | 25,000.00 |
| Dec 31, 2022 | -223.09 Mn |
| Sep 30, 2022 | 30,000.00 |
| Jun 30, 2022 | -176.78 Mn |
| Mar 31, 2022 | -155.30 Mn |
| Sep 30, 2021 | -117.09 Mn |
| Jun 30, 2021 | -106.30 Mn |
| Mar 31, 2021 | -80.38 Mn |